...
首页> 外文期刊>Neoplasma: Journal of Experimental and Clinical Oncology >Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
【24h】

Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.

机译:非霍奇金淋巴瘤细胞周期数据的预后相关性。

获取原文
获取原文并翻译 | 示例
           

摘要

Determination of proliferative activity of non-Hodgkin's lymphomas (NHL), aimed at improving the prediction of their clinical behavior, has gained considerable attention in the recent years. Flow cytometry has allowed rapid measurement of the cellular DNA content in terms of ploidy and proliferative activity. Flow cytometric DNA analysis was performed on paraffin embedded biopsy specimens taken from 125 patients with NHL. In 90 of them, proliferative index (PI) could be accurately measured and correlated with histology grade of the Working Formulation (WF). Intermediate and high grade NHL (54 patients) were analyzed together as HG-NHL. With the discrimination point for PI of 10%, the survival of high and low proliferative lymphomas was compared in the whole NHL group and within the WF prognostic groups. The median PI was 5% in LG (low grade) NHL and 10% in HG (high grade) NHL group. Acturial survival in NHL with high proliferative activity (39 patients) was 31% at 5 years and 15% at 10 years, and in NHL with low proliferative activity (51 patients) 53% and 18%, respectively (p = 0.002). In HG-NHL, survival at 5 years for low proliferative cases was 55% and for high proliferative cases 28% (p = 0.065), whereas in the LG-NHL group it was 54% and 28%, respectively (p = 0.059). The survival at 10 years was nearly equal in all groups. Proliferative index was associated with the overall survival of NHL in the whole group, as well as within the LG and HG prognostic categories. PI could differentiate more and less aggressive NHLs both within LG-NHL and HG-NHL. A tendency of survival curves toward continuous relapse was observed in low proliferative NHL and a tendency toward "plateau" in high proliferative NHL, irrespective of the histology grade.
机译:近年来,非霍奇金淋巴瘤(NHL)的增殖活性的测定,旨在改善其临床行为的预测,已引起了广泛的关注。流式细胞术已经可以根据倍性和增殖活性快速测量细胞DNA的含量。对125例NHL患者的石蜡包埋的活检标本进行了流式细胞DNA分析。在其中的90种中,可以准确地测量增殖指数(PI),并将其与工作配方(WF)的组织学等级相关联。中级和高级NHL(54例患者)一起作为HG-NHL进行分析。 PI的鉴别点为10%,比较了整个NHL组和WF预后组中高,低增殖性淋巴瘤的存活率。 LG(低级)NHL组中位数PI为5%,而HG(高级)NHL组中位数PI为10%。具有高增殖活性的NHL(39例患者)的5年和10年生存率分别为31%和51%,而具有低增殖活性的NHL(51例患者)的实际存活率分别为53%和18%(p = 0.002)。在HG-NHL中,低增生病例的5年生存率为55%,高增生病例为28%(p = 0.065),而LG-NHL组分别为54%和28%(p = 0.059)。 。所有组的10年生存率几乎相等。增殖指数与整个组以及LG和HG预后类别中NHL的总体生存率相关。 PI可以区分LG-NHL和HG-NHL中越来越少的侵略性NHL。在低增殖性NHL中观察到存活曲线趋向于连续复发的趋势,而在高增殖性NHL中观察到趋于“平稳”的趋势,而与组织学等级无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号